Outcomes in Patients with Cancer-Associated Venous Thromboembolism Receiving Immune Checkpoint Inhibitors: A Matched Cohort Study

被引：0
|
作者：
Danielian, Pedro Luiz Lage Bodour [1 ]
Dave, Heloni M. [2 ]
Wei, Wei [3 ]
Patel, Mehrie H. [1 ]
Angelini, Dana Elizabeth [1 ]
Khorana, Alok A. [1 ]
机构：
[1] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH USA
[2] Cleveland Clin, Akron, OH USA
[3] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-211304
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5578 / 5579
页数：2
相关论文
共 50 条
  • [21] Cardiovascular and thromboembolic outcomes with immune checkpoint inhibitors in gastroesophageal cancer: a propensity score-matched cohort study
    Bahar, Furkan
    Ibis, Betul
    Colak, Sena Cakir
    Banga, Akshat
    Song, Junmin
    Chang, Yu-Cheng
    Chi, Kuan-Yu
    Chang, Yu
    Chiang, Cho-Hung
    Chiang, Cho-Han
    GASTRIC CANCER, 2025, : 550 - 555
  • [22] Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
    Sogaard, Mette
    Nielsen, Peter Bronnum
    Skjoth, Flemming
    Kjaeldgaard, Jette Nordstrom
    Larsen, Torben Bjerregaard
    CANCER MEDICINE, 2019, 8 (03): : 1044 - 1053
  • [23] A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors
    Hata, Hiroki
    Matsumura, Chikako
    Chisaki, Yugo
    Nishioka, Kae
    Tokuda, Misaki
    Miyagi, Kazuyo
    Suizu, Tomoki
    Yano, Yoshitaka
    CANCER CONTROL, 2022, 29
  • [24] Home treatment for patients with cancer-associated venous thromboembolism
    Sanchez, Olivier
    Roy, Pierre-Marie
    Gaboreau, Yoann
    Schmidt, Jeannot
    Moustafa, Fares
    Benmaziane, Asmahane
    Elias, Antoine
    Espitia, Olivier
    Sevestre, Marie-Antoinette
    Couturaud, Francis
    Mahe, Isabelle
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2024, 117 (01) : 16 - 28
  • [25] Development and validation of a nomogram model for predicting venous thromboembolism risk in lung cancer patients treated with immune checkpoint inhibitors: A cohort study in China
    Liang, Guanzhong
    Hu, Zuhai
    Xu, Qianjie
    Wang, Guixue
    Wang, Ying
    Li, Xiaosheng
    Zhang, Wei
    Lei, Haike
    CANCER MEDICINE, 2024, 13 (16):
  • [26] Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy
    Kuderer, Nicole M.
    Poniewierski, Marek S.
    Culakova, Eva
    Lyman, Gary H.
    Khorana, Alok A.
    Pabinger, Ingrid
    Agnelli, Giancarlo
    Liebman, Howard A.
    Vicaut, Eric
    Meyer, Guy
    Shepherd, Frances A.
    BLOOD, 2016, 128 (22)
  • [27] Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors
    Icht, Oded
    Darzi, Naama
    Shimony, Shai
    Jacobi, Oded
    Reinhorn, Daniel
    Landman, Yosef
    Mutai, Raz
    Averbuch, Itamar
    Shochat, Tzippy
    Spectre, Galia
    Raanani, Pia
    Rotem, Ofer
    Dudnik, Elizabeth
    Peled, Nir
    Zer, Alona
    Leader, Avi
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (05) : 1250 - 1258
  • [28] Hyperprogression in Patients With Cancer Receiving Immune Checkpoint Inhibitors
    Sehgal, Kartik
    JAMA NETWORK OPEN, 2021, 4 (03)
  • [29] Biomarker Assessment of Venous Thromboembolism in Cancer Patients Receiving Checkpoint Blockade
    Swaidani, Shadi
    Roopkumar, Joanna
    Jun-Shim, Young
    Charles, Cathy
    Paul, Slato
    Kundu, Suman
    Funchain, Pauline
    Rayman, Patricia
    Pavicic, Paul G.
    Diaz-Montero, C. Marcela
    Khorana, Alok A.
    McCrae, Keith R.
    BLOOD, 2019, 134
  • [30] DOAC in the treatment of cancer-associated venous thromboembolism: a retrospective cohort study beyond the guidelines
    Mattia Cominacini
    Silvia Suardi
    Giulia Ferrari
    Roberto Ciresa
    Federica Tosi
    Sergio De Marchi
    Maria Teresa Valenti
    Luca Dalle Carbonare
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5773 - 5779
12345